WESTBOROUGH, MA--(Marketwire - February 19, 2008) - IBC’s 3rd Annual Nucleic Acids Technologies for Diagnostics is scheduled to take place on May 20-21, 2008 at the Red Rock Casino, Resort & Spa in Las Vegas, Nevada. This event is a forum for suppliers and end-users to forge collaborations and discuss the technological, regulatory, operational and business considerations surrounding the manufacturing of IVDs. It is designed to provide information on developments in regulatory pathways, business landscape and emerging technologies. Delegates will have the opportunity to meet with those involved in development, application and validation of methods for synthesis, modification, purification and characterization of any type of oligonucleotide for IVD and therapeutic applications. Presentations on recent U.S. and international regulatory developments from FDA and industrial specialists will highlight management insights and important business trends in the IVD market. The blend of presentations at Nucleic Acids Technologies for Diagnostics deals with new technologies and scientific developments together with business and regulatory considerations.
